drugset / Trial / NCT03583307
Efficacy and Safety of Sirolimus to Vascular Anomalies
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy of Sirolimus in complicated vascular anomalies in Chinese children
Timeline
- Start
- 2018-06-01
- Primary completion
- 2021-02-19
- Completion
- 2021-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 0.8 mg/m2 | Oral |
Indications
No indication recorded.